The deadly quartet - The insulin resistance syndrome

Southern Medical Journal

Volumn 90, Issue 12, 1997, Pages 1162-1169

  Opara, James U ^a,b   Levine, John H ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GEMFIBROZIL; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET THERAPY; DYSLIPIDEMIA; GLUCOSE UTILIZATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INSULIN RESISTANCE; OBESITY; SYNDROME;

EID: 0030696968     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Harris MI, Hadden WC, Knowler WC, et al: Prevalence of diabetes mellitus and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36:523-534
2. Haffner SM, Hazuda HP, Mitchell BD, et al: Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991; 14:102-108
3. Knowler WC, Pettlet DJ, Saad MF, et al: Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990; 6:1-27
4. Report of the Secretary's Task Force on Black and Minority Health. Executive Summary. Washington, DC, US Department of Health and Human Services, 1985
5. King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes 1993; 16:157-177
6. Haffner SM, Stem MP, Hazuda HP, et al: Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315:220-224
7. Gohdes D: Diabetes in North American Indians and Alaska Natives. Diabetes in America (NIH Publication No. 95-1468:683-701). Washington, DC, US Department of Health and Human Services, 1995
8. Abraira C, Johnson N, Colwell J, et al: VA cooperative study on glycemic control and complications in type II diabetes. (VA CSDM); results of the completed feasibility trial (Abstract). Presented at the 54th Annual Meeting and Scientific Sessions, American Diabetes Association, New Orleans, 1994
9. Harris MI, Easman RC, Siebert C: The DCCT and medical care for diabetes in the U.S. Diabetes Care 1994; 17:761-764
10. Lillioja S, Mott DM, Zawadzski JK, et al: In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987; 36:1329-1335
11. Prochazca M, Thompson B, Scherer SW, et al: Linkage and association of insulin resistance and NIDDM with markers at 7q21.3-q22.1 in the Pima Indians. Diabetes 1995; 44:42A
12. Newman B, Selby JV, King MC, et al: Concordance for type 2 (non-insulin dependent) diabetes mellitus in male twins. Diabetologia 1987; 30:763-768
13. Barnett AH, Eff C, Leslie RD, et al: Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20:87-93
14. Kolterman OG, Inset J, Saekow M, et al: Mechanism of insulin resistance in human obesity: evidence for receptor and post receptor defects. J Clin Invest 1980; 65:1273-1284
15. DeFronzo RA, Diebert D, Hendler R, et al: Insulin sensitivity and insulin binding in maturity onset diabetes. J Clin Invest 1979; 63:939-946
16. Kolterman OG, Gray RS, Griffin J, et al: Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 1981; 68:957-969
17. Olefsky JM, Kolterman OG, Scarlett JA: Insulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. Am J Physiol 1982; 243:E15-E30
18. Kahn CR, Cretazz M: Insulin receptors and the molecular mechanism of insulin action. Diabetes Metab Rev 1985; 1:5-32
19. Perseghin G, Price BT, Petersen FK, et al: Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin resistant subjects. N Engl J Med 1996; 335:1357-1358
20. Saltiel AR: Second messengers of insulin action. Diabetes Care 1990; 13:244-256
21. Kasuga M, Fujita-Yamaguchi Y, Blite DL, et al: Tyrosine specific protein kinase activity is associated with purified insulin receptor. Proc Natl Acad Sci USA 1983; 80:2137-2141
22. Rosen OM: Banting Lecture 1989: Structure and function of insulin receptors. Diabetes 1989; 38:1508-1511
23. Kahn B, Cushman SW: Subcellular translocation of glucose transporters: role of insulin action and its perturbation in altered metabolic states. Diabetes Metab Rev 1985; 1:203-228
24. U.K. Prospective Diabetes Study Group: U.K. Prospective diabetes study 16: progressive nature of type 2 diabetes. Diabetes 1995; 44:1249-1258
25. Rudenski AS, Hadden DR, Atkinson AB, et al: Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Med 1985; 5:36-41
26. Consoli A, Nurjhan N, Capani F, et al: Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989; 38:550-557
27. DeFronzo RA: The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21:165-171
28. Skott P, Hother-Nielsen O, Brunn NE, et al: Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989; 32:694-699
29. Endre T, Mattiasson I, Berglund G, et al: Insulin and renal sodium retention in hypertension-prone men. Hypertension 1994; 23:313-319
30. Rowe JW, Young JB, Minaker KL, et al: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal men. Diabetes 1981; 30:219-225
31. Hall JE, Brands MW, Hildebrandt DA, et al: Obesity-associated hypertension: hyperinsulinemia and renal mechanisms. Hypertension 1992; 19(suppl 1):1-45
32. Baron AD, Brechtel-Hook G, Johnson A, et al: Skeletal muscle blood flow. a possible link between insulin resistance and blood pressure. Hypertension 1993; 21:129-135
33. DeFronzo RA, Cooke CR, Andres R, et al: The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in men. J Clin Invest 1975; 55:845-855
34. Sims EAH, Danford E, Horton ES, et al: Endocrine and metabolic effects of experimental obesity in men. Recent Prog Horm Res 1973; 29:457-496
35. DeFronzo RA, Sherwin RS, Hendler R, et al: Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 1978; 62:204-213
36. Bonadonna R, Groop L, Kraemer N, et al: Obesity and insulin resistance in man: a dose response study. Metabolism 1990; 39:452-459
37. Golay A, Felber JP, Jequier E, et al: Metabolic basis of obesity and non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1988; 4:727-747
38. Franz MJ, Horton ES, Bantle JP, et al: Nutrition principles for the management of diabetes and related complications. Diabetes Care 1994; 17:490-518
39. Anderson JW, Smith BM, Geil PB: High fiber diet for diabetes. Postgrad Med J 1990; 88:157-167
40. Gohdes D: Diet therapy for minority patients with diabetes. Diabetes Care 1988; 11:189-191
41. Gray DS: The clinical use of dietary fiber. Am Fam Physician 1995; 51:419-426
42. Bailey CJ, Turner RC: Drug therapy. N Engl J Med 1996; 334:574-575
43. Iwamoto Y, Kuzuya T, Matsuda A, et al: Effects of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 1991; 14:1083
44. Fujiwara T, Yoshioka S, Yoshioka T, et al: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker Fatty Rats. Diabetes 1988; 37:1549-1588
45. Giaraldi TP, Gilmore A, Olefsky JM, et al: In vitro studies on the action of CS-045: a new antidiabetic agent. Metabolism 1990; 39:1056-1062
46. Pollare T, Lithell H, Berne C: A comparison of effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321:868-873
47. Ferriere M, Lachker H, Richard JL, et al: Captopril and insulin sensitivity. Ann Intern Med 1985; 102:134-135
48. Rett K, Janch KW, Wicklmayer M, et al: Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J 1986; 62(suppl 1):59-64
49. Turner R, Cull C, Holman R: United Kingdom prospective diabetes study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin dependent diabetes mellitus. Ann Intern Med 1996; 124:136-145
50. Carter JS, Pugh JA, Monterrosa A: Non-insulin dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125:227